Qrg Capital Management, Inc. Ironwood Pharmaceuticals Inc Transaction History

Qrg Capital Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$8.32 - $15.45 $72,750 - $135,094	-8,744 Reduced 3.38%	250,227 $2.18 Billion
Q4 2023 Feb 07, 2024	SELL	$8.79 - $11.51 $86,590 - $113,385	-9,851 Reduced 3.66%	258,971 $2.96 Billion
Q3 2023 Nov 13, 2023	BUY	$8.25 - $11.35 $2.22 Million - $3.05 Million	268,822 New	268,822 $2.59 Billion

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $562M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Qrg Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Qrg Capital Management, Inc. with notifications on news.